The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease
HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and it...
Ausführliche Beschreibung
Autor*in: |
Gauthier, Alex [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2018transfer abstract |
---|
Übergeordnetes Werk: |
Enthalten in: New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells - Wu, Zhi-Sheng ELSEVIER, 2020, the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research, New York, NY [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:120 ; year:2018 ; day:20 ; month:05 ; pages:88 |
Links: |
---|
DOI / URN: |
10.1016/j.freeradbiomed.2018.04.291 |
---|
Katalog-ID: |
ELV043056881 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV043056881 | ||
003 | DE-627 | ||
005 | 20230626002955.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180726s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.freeradbiomed.2018.04.291 |2 doi | |
028 | 5 | 2 | |a GBV00000000000233A.pica |
035 | |a (DE-627)ELV043056881 | ||
035 | |a (ELSEVIER)S0891-5849(18)30456-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 |a 610 | |
082 | 0 | 4 | |a 570 |q DE-600 |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 620 |q VZ |
084 | |a 52.57 |2 bkl | ||
084 | |a 53.36 |2 bkl | ||
100 | 1 | |a Gauthier, Alex |e verfasserin |4 aut | |
245 | 1 | 4 | |a The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease |
264 | 1 | |c 2018transfer abstract | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. | ||
520 | |a HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. | ||
700 | 1 | |a Sitapara, Ravi |4 oth | |
700 | 1 | |a Wang, Mao |4 oth | |
700 | 1 | |a Antoine, Dan |4 oth | |
700 | 1 | |a Mantell, Lin |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Wu, Zhi-Sheng ELSEVIER |t New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells |d 2020 |d the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research |g New York, NY [u.a.] |w (DE-627)ELV003689417 |
773 | 1 | 8 | |g volume:120 |g year:2018 |g day:20 |g month:05 |g pages:88 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.freeradbiomed.2018.04.291 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
936 | b | k | |a 52.57 |j Energiespeicherung |q VZ |
936 | b | k | |a 53.36 |j Energiedirektumwandler |j elektrische Energiespeicher |q VZ |
951 | |a AR | ||
952 | |d 120 |j 2018 |b 20 |c 0520 |h 88 |y 120.2018, S88- | ||
953 | |2 045F |a 570 |
author_variant |
a g ag |
---|---|
matchkey_str |
gauthieralexsitapararaviwangmaoantoineda:2018----:hrdxeuainfaaesoitdoeuaptenoeue |
hierarchy_sort_str |
2018transfer abstract |
bklnumber |
52.57 53.36 |
publishDate |
2018 |
allfields |
10.1016/j.freeradbiomed.2018.04.291 doi GBV00000000000233A.pica (DE-627)ELV043056881 (ELSEVIER)S0891-5849(18)30456-8 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 620 VZ 52.57 bkl 53.36 bkl Gauthier, Alex verfasserin aut The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease 2018transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. Sitapara, Ravi oth Wang, Mao oth Antoine, Dan oth Mantell, Lin oth Enthalten in Elsevier Wu, Zhi-Sheng ELSEVIER New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells 2020 the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research New York, NY [u.a.] (DE-627)ELV003689417 volume:120 year:2018 day:20 month:05 pages:88 https://doi.org/10.1016/j.freeradbiomed.2018.04.291 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.57 Energiespeicherung VZ 53.36 Energiedirektumwandler elektrische Energiespeicher VZ AR 120 2018 20 0520 88 120.2018, S88- 045F 570 |
spelling |
10.1016/j.freeradbiomed.2018.04.291 doi GBV00000000000233A.pica (DE-627)ELV043056881 (ELSEVIER)S0891-5849(18)30456-8 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 620 VZ 52.57 bkl 53.36 bkl Gauthier, Alex verfasserin aut The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease 2018transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. Sitapara, Ravi oth Wang, Mao oth Antoine, Dan oth Mantell, Lin oth Enthalten in Elsevier Wu, Zhi-Sheng ELSEVIER New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells 2020 the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research New York, NY [u.a.] (DE-627)ELV003689417 volume:120 year:2018 day:20 month:05 pages:88 https://doi.org/10.1016/j.freeradbiomed.2018.04.291 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.57 Energiespeicherung VZ 53.36 Energiedirektumwandler elektrische Energiespeicher VZ AR 120 2018 20 0520 88 120.2018, S88- 045F 570 |
allfields_unstemmed |
10.1016/j.freeradbiomed.2018.04.291 doi GBV00000000000233A.pica (DE-627)ELV043056881 (ELSEVIER)S0891-5849(18)30456-8 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 620 VZ 52.57 bkl 53.36 bkl Gauthier, Alex verfasserin aut The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease 2018transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. Sitapara, Ravi oth Wang, Mao oth Antoine, Dan oth Mantell, Lin oth Enthalten in Elsevier Wu, Zhi-Sheng ELSEVIER New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells 2020 the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research New York, NY [u.a.] (DE-627)ELV003689417 volume:120 year:2018 day:20 month:05 pages:88 https://doi.org/10.1016/j.freeradbiomed.2018.04.291 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.57 Energiespeicherung VZ 53.36 Energiedirektumwandler elektrische Energiespeicher VZ AR 120 2018 20 0520 88 120.2018, S88- 045F 570 |
allfieldsGer |
10.1016/j.freeradbiomed.2018.04.291 doi GBV00000000000233A.pica (DE-627)ELV043056881 (ELSEVIER)S0891-5849(18)30456-8 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 620 VZ 52.57 bkl 53.36 bkl Gauthier, Alex verfasserin aut The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease 2018transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. Sitapara, Ravi oth Wang, Mao oth Antoine, Dan oth Mantell, Lin oth Enthalten in Elsevier Wu, Zhi-Sheng ELSEVIER New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells 2020 the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research New York, NY [u.a.] (DE-627)ELV003689417 volume:120 year:2018 day:20 month:05 pages:88 https://doi.org/10.1016/j.freeradbiomed.2018.04.291 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.57 Energiespeicherung VZ 53.36 Energiedirektumwandler elektrische Energiespeicher VZ AR 120 2018 20 0520 88 120.2018, S88- 045F 570 |
allfieldsSound |
10.1016/j.freeradbiomed.2018.04.291 doi GBV00000000000233A.pica (DE-627)ELV043056881 (ELSEVIER)S0891-5849(18)30456-8 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 620 VZ 52.57 bkl 53.36 bkl Gauthier, Alex verfasserin aut The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease 2018transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. Sitapara, Ravi oth Wang, Mao oth Antoine, Dan oth Mantell, Lin oth Enthalten in Elsevier Wu, Zhi-Sheng ELSEVIER New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells 2020 the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research New York, NY [u.a.] (DE-627)ELV003689417 volume:120 year:2018 day:20 month:05 pages:88 https://doi.org/10.1016/j.freeradbiomed.2018.04.291 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 52.57 Energiespeicherung VZ 53.36 Energiedirektumwandler elektrische Energiespeicher VZ AR 120 2018 20 0520 88 120.2018, S88- 045F 570 |
language |
English |
source |
Enthalten in New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells New York, NY [u.a.] volume:120 year:2018 day:20 month:05 pages:88 |
sourceStr |
Enthalten in New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells New York, NY [u.a.] volume:120 year:2018 day:20 month:05 pages:88 |
format_phy_str_mv |
Article |
bklname |
Energiespeicherung Energiedirektumwandler elektrische Energiespeicher |
institution |
findex.gbv.de |
dewey-raw |
570 |
isfreeaccess_bool |
false |
container_title |
New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells |
authorswithroles_txt_mv |
Gauthier, Alex @@aut@@ Sitapara, Ravi @@oth@@ Wang, Mao @@oth@@ Antoine, Dan @@oth@@ Mantell, Lin @@oth@@ |
publishDateDaySort_date |
2018-01-20T00:00:00Z |
hierarchy_top_id |
ELV003689417 |
dewey-sort |
3570 |
id |
ELV043056881 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043056881</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626002955.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.freeradbiomed.2018.04.291</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000233A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043056881</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0891-5849(18)30456-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">52.57</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">53.36</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gauthier, Alex</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sitapara, Ravi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Mao</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antoine, Dan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mantell, Lin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Wu, Zhi-Sheng ELSEVIER</subfield><subfield code="t">New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells</subfield><subfield code="d">2020</subfield><subfield code="d">the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV003689417</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:120</subfield><subfield code="g">year:2018</subfield><subfield code="g">day:20</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:88</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.freeradbiomed.2018.04.291</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">52.57</subfield><subfield code="j">Energiespeicherung</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">53.36</subfield><subfield code="j">Energiedirektumwandler</subfield><subfield code="j">elektrische Energiespeicher</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">120</subfield><subfield code="j">2018</subfield><subfield code="b">20</subfield><subfield code="c">0520</subfield><subfield code="h">88</subfield><subfield code="y">120.2018, S88-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
|
author |
Gauthier, Alex |
spellingShingle |
Gauthier, Alex ddc 570 ddc 610 ddc 620 bkl 52.57 bkl 53.36 The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease |
authorStr |
Gauthier, Alex |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV003689417 |
format |
electronic Article |
dewey-ones |
570 - Life sciences; biology 610 - Medicine & health 620 - Engineering & allied operations |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
570 610 570 DE-600 610 DE-600 620 VZ 52.57 bkl 53.36 bkl The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease |
topic |
ddc 570 ddc 610 ddc 620 bkl 52.57 bkl 53.36 |
topic_unstemmed |
ddc 570 ddc 610 ddc 620 bkl 52.57 bkl 53.36 |
topic_browse |
ddc 570 ddc 610 ddc 620 bkl 52.57 bkl 53.36 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
r s rs m w mw d a da l m lm |
hierarchy_parent_title |
New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells |
hierarchy_parent_id |
ELV003689417 |
dewey-tens |
570 - Life sciences; biology 610 - Medicine & health 620 - Engineering |
hierarchy_top_title |
New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV003689417 |
title |
The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease |
ctrlnum |
(DE-627)ELV043056881 (ELSEVIER)S0891-5849(18)30456-8 |
title_full |
The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease |
author_sort |
Gauthier, Alex |
journal |
New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells |
journalStr |
New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science 600 - Technology |
recordtype |
marc |
publishDateSort |
2018 |
contenttype_str_mv |
zzz |
container_start_page |
88 |
author_browse |
Gauthier, Alex |
container_volume |
120 |
class |
570 610 570 DE-600 610 DE-600 620 VZ 52.57 bkl 53.36 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Gauthier, Alex |
doi_str_mv |
10.1016/j.freeradbiomed.2018.04.291 |
dewey-full |
570 610 620 |
title_sort |
redox regulation of damage-associated molecular pattern molecule hmgb1 in pulmonary disease |
title_auth |
The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease |
abstract |
HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. |
abstractGer |
HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. |
abstract_unstemmed |
HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
title_short |
The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease |
url |
https://doi.org/10.1016/j.freeradbiomed.2018.04.291 |
remote_bool |
true |
author2 |
Sitapara, Ravi Wang, Mao Antoine, Dan Mantell, Lin |
author2Str |
Sitapara, Ravi Wang, Mao Antoine, Dan Mantell, Lin |
ppnlink |
ELV003689417 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth |
doi_str |
10.1016/j.freeradbiomed.2018.04.291 |
up_date |
2024-07-06T17:48:58.873Z |
_version_ |
1803852855507943424 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043056881</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626002955.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.freeradbiomed.2018.04.291</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000233A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043056881</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0891-5849(18)30456-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">52.57</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">53.36</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gauthier, Alex</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The redox regulation of damage-associated molecular pattern molecule HMGB1 in pulmonary disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">HMGB1 is an endogenous molecule that can initiate and perpetuate inflammation. Previously, we have shown that airway HMGB1 mediates hyperoxia-induced acute lung injury and compromised innate immunity in cystic fibrosis and ventilator-associated pneumonia. To determine the redox state of HMGB1 and its effects on acute lung injury and innate immunity under hyperoxic conditions, LC-MS/MS was used to analyze HMGB1 in either bronchoalveolar lavage fluid (BAL) of mice or media of cultured macrophages exposed to 95–99% O2. MS/MS analysis indicated nuclear HMGB1 in both 95% and 21% O2 groups was in its reduced form, but in BAL or culture media, all three critical redox forms of HMGB1 were present. Extracellular HMGB1 was not detected in BAL or cultured macrophages that remained at 21% O2. GTS -21, a drug which can improve macrophage functions and alleviate hyperoxia-induced acute lung injury, kept extracellular HMGB1 in the reduced form. These data suggest that hyperoxia-induced oxidative modifications of HMGB1 occurred after its release into the airways. Strategies to prevent HMGB1 from oxidation may provide an effective approach to treat patients on ventilation with either lung injury and/or compromised host defense against bacterial infections.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sitapara, Ravi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Mao</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antoine, Dan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mantell, Lin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Wu, Zhi-Sheng ELSEVIER</subfield><subfield code="t">New organic dyes with varied arylamine donors as effective co-sensitizers for ruthenium complex N719 in dye sensitized solar cells</subfield><subfield code="d">2020</subfield><subfield code="d">the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV003689417</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:120</subfield><subfield code="g">year:2018</subfield><subfield code="g">day:20</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:88</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.freeradbiomed.2018.04.291</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">52.57</subfield><subfield code="j">Energiespeicherung</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">53.36</subfield><subfield code="j">Energiedirektumwandler</subfield><subfield code="j">elektrische Energiespeicher</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">120</subfield><subfield code="j">2018</subfield><subfield code="b">20</subfield><subfield code="c">0520</subfield><subfield code="h">88</subfield><subfield code="y">120.2018, S88-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
|
score |
7.3996572 |